Applied Therapeutics Total Non Current Liabilities 2011-2026 | APLT

Annual Total Non Current Liabilities Applied Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
797 K	878 K	891 K	1.33 M	1.68 M	-	6.25 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
6.25 M	797 K	1.97 M

Quarterly Total Non Current Liabilities Applied Therapeutics

2025-Q3	2025-Q2	2024-Q4	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
2.03 M	2.16 M	2.39 M	1.71 M	30 K	797 K	735 K	792 K	825 K	878 K	536 K	655 K	773 K	891 K	1 M	1.11 M	1.22 M	1.33 M	1.33 M	1.33 M	1.33 M	1.68 M	1.68 M	1.68 M	1.68 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.39 M	30 K	1.22 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
NextCure NXTC	2.6 M	$ 12.67	0.52 %	$ 354 M	USA
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Liquidia Corporation LQDA	10.3 M	$ 34.25	-0.38 %	$ 2.23 B	USA
Shattuck Labs STTK	22.3 M	$ 5.02	6.13 %	$ 214 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
AbCellera Biologics ABCL	326 M	$ 3.58	-1.38 %	$ 1.07 B	Canada
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
ADMA Biologics ADMA	99.5 M	$ 15.57	-5.89 %	$ 3.71 B	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Aptorum Group Limited APM	2.21 M	$ 0.82	-0.73 %	$ 4.47 M	China
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Anika Therapeutics ANIK	26.1 M	$ 14.19	-1.18 %	$ 208 M	USA
ANI Pharmaceuticals ANIP	182 M	$ 75.6	-1.22 %	$ 1.46 B	USA
Apellis Pharmaceuticals APLS	289 M	$ 20.24	1.91 %	$ 2.55 B	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Athersys ATHX	5.4 M	-	3.77 %	$ 22.4 M	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.5	-8.28 %	$ 383 M	Britain
AVEO Pharmaceuticals AVEO	14.7 M	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	48.9 M	$ 159.87	-2.57 %	$ 7.95 B	USA
BridgeBio Pharma BBIO	97.6 M	$ 65.73	-1.22 %	$ 12.6 B	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Brainstorm Cell Therapeutics BCLI	618 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
Bellerophon Therapeutics BLPH	1.93 M	-	-74.18 %	$ 955 K	USA
Bellicum Pharmaceuticals BLCM	48 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
BioLineRx Ltd. BLRX	8.22 M	$ 2.72	-3.31 %	$ 908 M	Israel
BioMarin Pharmaceutical BMRN	635 M	$ 60.54	0.18 %	$ 11.6 B	USA
CymaBay Therapeutics CBAY	1.26 M	-	-	$ 3.45 B	USA
Codexis CDXS	28.2 M	$ 1.25	16.2 %	$ 91.8 M	USA
Cabaletta Bio CABA	43.9 M	$ 3.2	-6.71 %	$ 3.74 M	USA